Kim, M.D. v. NRAD Medical Associates, P.C.

CourtUnited States Bankruptcy Court, E.D. New York
DecidedJanuary 26, 2024
Docket8-20-08157
StatusUnknown

This text of Kim, M.D. v. NRAD Medical Associates, P.C. (Kim, M.D. v. NRAD Medical Associates, P.C.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kim, M.D. v. NRAD Medical Associates, P.C., (N.Y. 2024).

Opinion

UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF NEW YORK X In re: Chapter 11 NRAD MEDICAL ASSOCIATES, P.C., Case No. 15-72898 (LAS) Debtor. X ALICE KIM, M.D., CORINNE TOBIN, M.D., Adv. Pro. No. 20-08157 (LAS) DAVID KAPLAN, M.D., ELIZABETH LUSTRIN, M.D., JAY BOSWORTH, M.D., JED POLLACK, M.D., COLETTE ZITO, AS EXECUTOR OF THE ESTATE OF JOSEPH ZITO M.D., AND JULIAN SAFIR, M.D.,

Plaintiffs,

-against-

NRAD MEDICAL ASSOCIATES, P.C.

Defendant. X

MEMORANDUM DECISION AND ORDER ON CROSS-MOTIONS FOR SUMMARY JUDGMENT Plaintiffs Alice Kim, M.D., Corinne Tobin, M.D., David Kaplan, M.D., Elizabeth Lustrin, M.D., Jay Bosworth, M.D., Jed Pollack, M.D., Colette Zito, as Executor of the Estate of Joseph Zito M.D., and Julian Safir, M.D. (collectively, “Plaintiffs”) commenced this adversary proceeding against NRAD Medical Associates, P.C. (“NRAD” or “Debtor”) alleging that the proceeds received by NRAD from the demutualization of Medical Liability Mutual Insurance Company (“MLMIC”) constitute property of the estate and must be distributed to Plaintiffs in respect of their allowed general unsecured claims in accordance with NRAD’s confirmed chapter 11 plan. Plaintiffs also allege that NRAD did not disclose the medical malpractice insurance policies during the plan negotiation process and failed to disclose the policies and demutualization plan when NRAD requested, post-confirmation, that Plaintiffs discount their maximum distribution under the confirmed chapter 11 plan by 13.33%, i.e., a discount of $999,750, in connection with NRAD’s sale of its ownership interest in Meridian Imaging Group, LLC to NYU Langone Medical Center. According to Plaintiffs, had they known that NRAD was eligible to receive proceeds from the MLMIC demutualization, they would not have agreed to discount the maximum distribution by accepting a payout from the proceeds received by NRAD from the NYU-Meridian transaction. Plaintiffs contend that the failure to disclose the medical malpractice insurance policies and the demutualization plan

has enabled the current shareholders to reap the benefit of the $999,750 discount and renders NRAD accountable under theories of negligent misrepresentation, fraudulent inducement, fraudulent concealment, and breach of fiduciary duty. Correspondingly, Plaintiffs claim they should not be bound by the agreement to discount their maximum distribution under NRAD’s confirmed chapter 11 plan. For its part, NRAD has a different view as to the disposition of the proceeds from the demutualization of MLMIC. NRAD contends that the medical malpractice insurance policies in question were terminated prior to the commencement of its chapter 11 case. Thus, NRAD argues that it had no duty to disclose the policies during its chapter 11 case or thereafter, and that neither the policies themselves nor any of the proceeds received by NRAD from the MLMIC demutualization constitute property of the estate available for distribution to Plaintiffs in respect of their allowed unsecured claims. NRAD, therefore, maintains that Plaintiffs first claim for relief to enforce the chapter 11 plan and distribute the proceeds to Plaintiffs fails. NRAD further argues that Plaintiffs’ remaining claims for relief for negligent representation, fraudulent inducement, fraudulent concealment, and breach of fiduciary duty likewise fail because (i) each of these claims is predicated on a finding that the policies and the proceeds received from the MLMIC demutualization are property of the estate, (ii) NRAD

was not aware of the demutualization plan at the time it negotiated the discounted maximum distribution due Plaintiffs under the confirmed chapter 11 plan, and (iii) Plaintiffs are bound by the terms of the agreement under which they consented to the NYU-Meridian transaction and reduced their maximum distribution under the confirmed chapter 11 plan by 13.33%. Now pending before the Court are two motions for summary judgment. The first is a Motion for Summary Judgment (“NRAD SJ Mot.”) (Dkt. No. 46) filed by NRAD seeking judgment in its favor on all five claims for relief asserted in the Complaint predicated on its central argument that proceeds received from the MLMIC demutualization are not property

of the estate subject to distribution under its confirmed chapter 11 plan. The second is a Motion for Summary Judgment (“Pl. SJ Mot.”) (Dkt. No. 47) filed by Plaintiffs seeking judgment in their favor on the first claim for relief in the Complaint determining that the proceeds derived from the MLMIC demutualization are property of the estate and must be distributed in accordance with NRAD’s confirmed chapter 11 plan. Thus, the threshold question, and the heart of this dispute, is whether the demutualization proceeds constitute property of the estate. The Court carefully reviewed the parties’ submissions and heard oral argument on the motions. For the reasons set forth below, the Court grants Plaintiffs’ motion and denies NRAD’s motion as to the first claim for relief. The Court also denies NRAD’s motion as to the second, third, fourth, and fifth claims for relief. JURISDICTION The Court has jurisdiction over this adversary proceeding pursuant to 28 U.S.C. § 1334(b) and the Standing Order of Reference of the United States District Court for the Eastern District of New York, dated August 28, 1986 (Weinstein, C.J.), as amended by Order dated December 5, 2012 (Amon, C.J.) entered in accordance with 28 U.S.C. § 157(a). BACKGROUND1 I. NRAD’S PREPETITION OPERATIONS Plaintiffs are former shareholders of NRAD and creditors of NRAD’s bankruptcy estate. JSF ¶ 1. NRAD was a professional corporation, organized under the laws of the State of New York, that operated a regional radiology imaging medical practice and a regional radiation therapy practice until June 1, 2015. Id. ¶¶ 2-3. For several years prior to and as of the Petition Date, NRAD was owned by the current

shareholders: Robert V. Blake, M.D., Paul D. Cayea, M.D., Paul S. Lang, M.D., Robin Ehrenpreis, M.D., Daniel Benjamin, M.D., Gene Berkovich, M.D. Eric Schnipper, M.D., and Paul Schorr, M.D (collectively, the “Current Shareholders”). Id. ¶ 4. In connection with NRAD’s operations, NRAD employed various physicians, including Plaintiffs, Bilha Fish, M.D., Geraldine McGinty, M.D., Joshua Kern, M.D., Kim Podolnick, M.D., Leslie Feld, M.D., Lori Kelly, M.D., and Nina Vincoff, M.D. (collectively, and together with Plaintiffs, the “Former Shareholders”). Id. ¶ 5. The Former Shareholders tendered their shares in 2013 and 2014. Id. ¶ 6. In return for the tender of their shares, the Former Shareholders received promissory notes (collectively, the “Redemption Notes”) under various redemption agreements entered into with NRAD in 2013 and 2014 (collectively, the “Redemption Agreements”), as provided for in the operative Shareholder’s Agreement. Id. ¶ 7. On November 5, 2014, one of the Former Shareholders, Nina S. Vincoff, M.D. (“Vincoff”), commenced an action in New York State Supreme Court, Nassau County, seeking payment in full on her Redemption Note. Id. ¶ 9; Vincoff v. NRAD, Index No. 605872/2014 (the “First Vincoff Action”).

1 The facts are drawn from the Joint Statement of Undisputed Facts (“JSF”) (Dkt. No. 47) filed by the parties pursuant to Federal Rule of Bankruptcy Procedure 7056 and Local Bankruptcy Rule 7056-1. Citations to the JSF incorporate by reference the materials cited therein. Capitalized terms used but not defined in this Memorandum Decision and Order shall have the meanings assigned to such terms in the JSF.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Segal v. Rochelle
382 U.S. 375 (Supreme Court, 1966)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Dickerson Ex Rel. Davison v. Napolitano
604 F.3d 732 (Second Circuit, 2010)
Porter v. Quarantillo
722 F.3d 94 (Second Circuit, 2013)
Hicks v. Baines
593 F.3d 159 (Second Circuit, 2010)
Chartschlaa v. Nationwide Mutual Insurance
538 F.3d 116 (Second Circuit, 2008)
In Re Hanley
305 B.R. 84 (M.D. Florida, 2003)
Drews v. Vote (In Re Vote)
261 B.R. 439 (Eighth Circuit, 2001)
Osan Ltd. v. ACCENTURE LLP
454 F. Supp. 2d 46 (E.D. New York, 2006)
Hydro Investors, Inc. v. Trafalgar Power Inc.
227 F.3d 8 (Second Circuit, 2000)
Mendelsohn v. Ross
251 F. Supp. 3d 518 (E.D. New York, 2017)
Oden v. Bos. Scientific Corp.
330 F. Supp. 3d 877 (E.D. New York, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Kim, M.D. v. NRAD Medical Associates, P.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kim-md-v-nrad-medical-associates-pc-nyeb-2024.